Litcius/Paper detail

Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases

Joonhong Jun, Jihyun Baek, Dahyun Kang, Hyungwoo Moon, Hyejin Kim, Hyunwook Cho, Jung‐Mi Hah

2022European Journal of Medicinal Chemistry15 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryADMEDocking (animal)In silicoImidazoleLipinski's rule of fiveDrug discoveryPharmacologyMoietyMolecular modelStereochemistryBiochemistryIn vitroBiologyMedicineGeneNursingMelanoma and MAPK PathwaysNuclear Receptors and SignalingComputational Drug Discovery Methods
Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases | Litcius